164 related articles for article (PubMed ID: 9739102)
21. The involvement of VEGF receptors and MAPK in the cannabinoid potentiation of Ca2+ flux into N18TG2 neuroblastoma cells.
Rubovitch V; Gafni M; Sarne Y
Brain Res Mol Brain Res; 2004 Jan; 120(2):138-44. PubMed ID: 14741403
[TBL] [Abstract][Full Text] [Related]
22. Delta opioid receptor down-regulation is independent of functional G protein yet is dependent on agonist efficacy.
Remmers AE; Clark MJ; Liu XY; Medzihradsky F
J Pharmacol Exp Ther; 1998 Nov; 287(2):625-32. PubMed ID: 9808689
[TBL] [Abstract][Full Text] [Related]
23. Opioid receptors are coupled tightly to G proteins but loosely to adenylate cyclase in NG108-15 cell membranes.
Costa T; Klinz FJ; Vachon L; Herz A
Mol Pharmacol; 1988 Dec; 34(6):744-54. PubMed ID: 2849042
[TBL] [Abstract][Full Text] [Related]
24. Site of pertussis toxin-induced ADP-ribosylation on Gi is critical for receptor modulation of GDP interaction with Gi.
Gosse ME; Frey EA; Cote TE
Mol Endocrinol; 1989 Feb; 3(2):315-24. PubMed ID: 2540429
[TBL] [Abstract][Full Text] [Related]
25. Supersensitivity to mu-opioid receptor-mediated inhibition of the adenylyl cyclase pathway involves pertussis toxin-resistant Galpha protein subunits.
Mostany R; Díaz A; Valdizán EM; Rodríguez-Muñoz M; Garzón J; Hurlé MA
Neuropharmacology; 2008 May; 54(6):989-97. PubMed ID: 18384820
[TBL] [Abstract][Full Text] [Related]
26. Properties of delta opioid receptor in neuroblastoma NS20Y: receptor activation and neuroblastoma proliferation.
Law PY; Bergsbaken C
J Pharmacol Exp Ther; 1995 Jan; 272(1):322-32. PubMed ID: 7815347
[TBL] [Abstract][Full Text] [Related]
27. Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands.
Zhu J; Luo LY; Li JG; Chen C; Liu-Chen LY
J Pharmacol Exp Ther; 1997 Aug; 282(2):676-84. PubMed ID: 9262330
[TBL] [Abstract][Full Text] [Related]
28. Down-regulation of mu-opioid receptor by full but not partial agonists is independent of G protein coupling.
Yabaluri N; Medzihradsky F
Mol Pharmacol; 1997 Nov; 52(5):896-902. PubMed ID: 9351981
[TBL] [Abstract][Full Text] [Related]
29. Molecular mechanisms involved in the asymmetric interaction between cannabinoid and opioid systems.
Viganò D; Rubino T; Vaccani A; Bianchessi S; Marmorato P; Castiglioni C; Parolaro D
Psychopharmacology (Berl); 2005 Nov; 182(4):527-36. PubMed ID: 16079992
[TBL] [Abstract][Full Text] [Related]
30. Azido- and isothiocyanato-substituted aryl pyrazoles bind covalently to the CB1 cannabinoid receptor and impair signal transduction.
Howlett AC; Wilken GH; Pigg JJ; Houston DB; Lan R; Liu Q; Makriyannis A
J Neurochem; 2000 May; 74(5):2174-81. PubMed ID: 10800963
[TBL] [Abstract][Full Text] [Related]
31. An assessment of the role of opioid receptors in the response to cannabimimetic drugs.
Devane WA; Spain JW; Coscia CJ; Howlett AC
J Neurochem; 1986 Jun; 46(6):1929-35. PubMed ID: 3009717
[TBL] [Abstract][Full Text] [Related]
32. The kappa opioid receptor expressed on the mouse R1.1 thymoma cell line is coupled to adenylyl cyclase through a pertussis toxin-sensitive guanine nucleotide-binding regulatory protein.
Lawrence DM; Bidlack JM
J Pharmacol Exp Ther; 1993 Sep; 266(3):1678-83. PubMed ID: 8103800
[TBL] [Abstract][Full Text] [Related]
33. Selective interactions of mu-opioid receptors with pertussis toxin-sensitive G proteins: involvement of the third intracellular loop and the c-terminal tail in coupling.
Georgoussi Z; Merkouris M; Mullaney I; Megaritis G; Carr C; Zioudrou C; Milligan G
Biochim Biophys Acta; 1997 Dec; 1359(3):263-74. PubMed ID: 9434132
[TBL] [Abstract][Full Text] [Related]
34. Differential regulation of the human kappa opioid receptor by agonists: etorphine and levorphanol reduced dynorphin A- and U50,488H-induced internalization and phosphorylation.
Li JG; Zhang F; Jin XL; Liu-Chen LY
J Pharmacol Exp Ther; 2003 May; 305(2):531-40. PubMed ID: 12606694
[TBL] [Abstract][Full Text] [Related]
35. Ligand-induced changes in surface mu-opioid receptor number: relationship to G protein activation?
Zaki PA; Keith DE; Brine GA; Carroll FI; Evans CJ
J Pharmacol Exp Ther; 2000 Mar; 292(3):1127-34. PubMed ID: 10688632
[TBL] [Abstract][Full Text] [Related]
36. Activation of adenylate cyclase by human recombinant sst5 receptors expressed in CHO-K1 cells and involvement of Galphas proteins.
Carruthers AM; Warner AJ; Michel AD; Feniuk W; Humphrey PP
Br J Pharmacol; 1999 Mar; 126(5):1221-9. PubMed ID: 10205012
[TBL] [Abstract][Full Text] [Related]
37. Opiate receptor down-regulation and desensitization in neuroblastoma X glioma NG108-15 hybrid cells are two separate cellular adaptation processes.
Law PY; Hom DS; Loh HH
Mol Pharmacol; 1983 Nov; 24(3):413-24. PubMed ID: 6314114
[TBL] [Abstract][Full Text] [Related]
38. Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1.
Bouaboula M; Poinot-Chazel C; Bourrié B; Canat X; Calandra B; Rinaldi-Carmona M; Le Fur G; Casellas P
Biochem J; 1995 Dec; 312 ( Pt 2)(Pt 2):637-41. PubMed ID: 8526880
[TBL] [Abstract][Full Text] [Related]
39. Methadone-induced desensitization of the delta-opioid receptor is mediated by uncoupling of receptor from G protein.
Liu JG; Liao XP; Gong ZH; Qin BY
Eur J Pharmacol; 1999 Jun; 374(2):301-8. PubMed ID: 10422772
[TBL] [Abstract][Full Text] [Related]
40. Effect of chronic D-Ala,2 D-Leu5-enkephalin or pertussis toxin treatment on the high-affinity state of delta opioid receptor in neuroblastoma x glioma NG108-15 hybrid cells.
Law PY; Hom DS; Loh HH
J Pharmacol Exp Ther; 1991 Feb; 256(2):710-6. PubMed ID: 1847209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]